June 2026 Edition

This directory began as a working tool. As an industrial biotechnology consultant, I wanted to keep track of companies active in the field, where they were located, what they did, how many people they have.

It's now a curated, consistently classified population of the companies that constitute this sector: 571 active organizations, each resolved to a single standardized record, sourced and verified entry by entry, and current as of a stated date (May 2026). $495 for the current edition. Every future edition will be $195 for existing purchasers.

Scope and Composition

The current directory profiles 571 active industrial biotechnology companies across North America, EMEA, and Asia-Pacific. Inclusion reflects a deliberate editorial scope: active biomanufacturers and the broader ecosystem around them; strain engineering, fermentation, bioprocessing, enzymology, and the equipment and contract-service providers that support them. Buyers of fermentation products, distributors, holding companies, are excluded by design, because their presence would dilute the precision that makes the population useful.

Data Architecture

Each company is resolved to a single standardized record, organized into clear functional layers:

Identity and location. Company name, official website, and a normalized geography; city, country, and a consolidated North America / EMEA / APAC region tag that supports clean territorial filtering rather than free-text country matching.

Profile and maturity. Development stage (startup, scaleup, or established), founding year, and funding status from pre-seed through later stages or public ownership. A LinkedIn reference is retained for your own verification.

Scale. A headcount estimate accompanied by a bucketed size band designed for rapid sorting of the population into size cohorts. The methodology tab documents how these figures are derived and discloses where they are known to undercount (for non-Western firms in particular) rather than presenting them as more precise than they are.

Classification and capability. The analytical core. Each company carries controlled-vocabulary keywords drawn from an approximately eighty-term taxonomy spanning host organisms, processes, enabling technologies, and end markets; a higher-level business-category grouping; and a technology-platform field describing the specific technical approach. Two narrative fields (a neutral business description and a biotech-involvement assessment) distinguish what the company as a whole is from what it actually does within industrial biotechnology and how central that activity is to its operations.

Funding and provenance. Where a company's most recent round has been publicly disclosed, the record captures round size, year, and named participants; coverage here is necessarily partial, as much of the population is undisclosed or pre-disclosure, and the field should be read as a disclosed-deal layer rather than comprehensive financial coverage. Every entry carries a source citation, and a dedicated methodology tab documents compilation practice.

The Investor-Intelligence Layer

Beyond the company population, the workbook includes two analytical tables that invert the data to a capital-flow view. The first maps each market segment to the breadth of distinct firms active in it and isolates those demonstrating repeat conviction rather than single-deal participation. The second presents a firm-by-segment matrix showing where individual investors are concentrating. Together they offer a view of the sector's genuine capital base as distinct from its transaction noise; a perspective that is laborious to assemble from raw funding records as classified areas of technology and is provided here ready to use.

Format and Delivery

The directory is delivered as a Microsoft Excel workbook (.xlsx), not a static PDF, because the product is a working dataset. You can sort, filter, and segment the full population on any field, reconcile it against your own account lists, and drop it directly into your existing workflow or LLM for analysis.

The workbook opens in Excel, Google Sheets, and other standard spreadsheet software, and is structured across multiple tabs: the classified company population, the two investor-intelligence tables, and a methodology tab documenting sources and definitions.

Editorial Method and Differentiation

The directory's differentiation is methodological rather than quantitative. Free databases compete on breadth and lose on discipline: thousands of entries, inconsistently tagged, with no mechanism to separate substance from self-description. This directory is curated and classified by a practicing industrial biotechnology consultant. The editorial posture is deliberately conservative - observable, company-level facts as faithfully as I could.

Who It's For

The directory is built for professionals who need the sector as a structured base rather than a narrative:

Business development and commercial teams at CROs, CDMOs, and service providers assembling qualified, segment-filtered target-account lists.

Equipment and bioprocess vendors sizing and mapping their addressable market.

Corporate development and R&D scouting functions maintaining awareness of the competitive and partnership landscape.

Strategic-intelligence and market-research teams requiring a clean, segmented population as the foundation for further analysis.

A Maintained Instrument

The value of a company population of this kind is sustained through maintenance. This directory is a versioned instrument, current as of its stated snapshot date and refreshed on a regular cadence to incorporate new entrants, retire defunct entities, and update headcount and funding signals as the sector moves. The immediate return is the elimination of weeks of manual reconstruction; the durable return is a maintained, consistently classified base from which repeatable market analysis becomes possible.

Industrial Biotechnology Company Directory

$495.00

Terms and Conditions — Industrial Biotechnology Company Directory

1. Acceptance of Terms
By purchasing or downloading this directory, you agree to be bound by these Terms and Conditions. If you do not agree, do not purchase or use this product.

2. Intellectual Property and Permitted Use
This directory — including its structure, its keyword taxonomy and classification system, and its compilation of data — is the intellectual property of Apex Bio Consulting. Your purchase grants you a limited, non-exclusive, non-transferable license to use this directory for your personal or internal business use.

Permitted use. You may use the directory and its data freely within your own organization. This includes importing the data into your own CRM, database, or internal tools; filtering, annotating, and enriching it; and combining it with your own data to support your internal business activities, including business development, market analysis, and research.

Prohibited use. You may not supply the directory or its data, in whole or in substantial part, to anyone outside your organization, or use it to create a product or service that competes with the directory. Specifically, you may not reproduce, publish, distribute, sublicense, sell, rent, or otherwise share the directory or its contents with any third party; make it available outside your organization through any database, system, or platform; or use the directory or its data to build, train, populate, or supplement any competing dataset, directory, product, or service offered to others.

The distinction is between internal use, which is permitted, and external distribution or the creation of a competing product, which is not.

3. Nature of the Directory
This directory is a reference publication provided for informational purposes only. It contains company profiles compiled from publicly available sources together with Apex Bio Consulting's own research, classification, and editorial analysis. It is not a substitute for your own independent due diligence and does not constitute professional, financial, investment, or legal advice, a recommendation, or an endorsement of any listed company or investor. Your purchase does not create a consultant-client or advisory relationship with Apex Bio Consulting.

4. Accuracy and Completeness
While we make reasonable efforts to ensure accuracy at the time of publication, we do not warrant that the information in this directory is accurate, complete, or current. Company descriptions, classifications, headcount figures, funding amounts, investor information, websites, and other data points are compiled and in many cases estimated from public sources, and may be incomplete, approximate, or out of date. Headcount figures and funding amounts in particular are estimates and should be treated as approximate, and classifications, stage descriptors, and similar fields represent the author's good-faith editorial judgment based on publicly available information as of the snapshot date, not statements of fact. Companies and their activities may change at any time without notice to us. This directory does not purport to be an exhaustive listing of all industrial biotechnology companies. The inclusion or exclusion of any company reflects editorial judgment and information availability, not an assessment of that company's quality, suitability, or financial condition.

5. Your Responsibility to Verify
You are solely responsible for independently verifying all information before relying on it for any purpose, including the selection, engagement, evaluation, or analysis of any listed company or investor. You should contact companies of interest directly and conduct your own due diligence before entering into any business relationship or transaction.

6. Disclaimer of Warranties
THIS DIRECTORY IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, OR COMPLETENESS. WE DO NOT WARRANT THE PERFORMANCE, RELIABILITY, FINANCIAL CONDITION, OR SUITABILITY OF ANY LISTED COMPANY OR INVESTOR.

7. Limitation of Liability
TO THE MAXIMUM EXTENT PERMITTED BY LAW, APEX BIO CONSULTING SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES ARISING FROM YOUR USE OF OR RELIANCE ON THIS DIRECTORY, INCLUDING BUT NOT LIMITED TO DAMAGES ARISING FROM ANY TRANSACTION OR RELATIONSHIP BETWEEN YOU AND ANY LISTED COMPANY OR INVESTOR. OUR TOTAL LIABILITY FOR ALL CLAIMS RELATING TO THIS DIRECTORY SHALL NOT EXCEED THE PURCHASE PRICE YOU PAID.

8. Edition and Updates
This directory is sold as a dated edition reflecting information compiled as of its stated snapshot date. Your purchase entitles you to the specific edition purchased. Apex Bio Consulting is under no obligation to provide updates, corrections, or future editions. Updated editions, if released, are offered as separate products for separate purchase, with returning-customer pricing offered to existing purchasers.

9. Refunds
Due to the digital nature of this product, all sales are final once the file has been downloaded.

10. Governing Law
These terms shall be governed by the laws of the State of Illinois. Any disputes shall be resolved exclusively in the courts of Champaign County, Illinois.

11. Changes
We may update these terms at any time. Changes apply to purchases made after the updated terms are posted.

Contact
Questions about these terms? Contact us at jamie.ryding@apexbio-consulting.com.

Industrial Biotechnology Company Directory

Terms and Conditions